Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
ACTIVE_NOT_RECRUITING
NCT03820947
VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial
506
Enrollment(s)
32
Study location(s)
INTERVENTIONAL (NA)
Venous Reflux
ACTIVE_NOT_RECRUITING
NCT05113251
Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer
927
Enrollment(s)
146
Study location(s)
INTERVENTIONAL (PHASE3)
Breast Neoplasms
Breast Cancer
HER2-positive Early Breast Cancer
RECRUITING
NCT04986579
Scalp Cooling in MBC
120
Enrollment(s)
2
Study location(s)
INTERVENTIONAL (PHASE2)
Metastatic Breast Cancer
Chemotherapy-induced Alopecia
ACTIVE_NOT_RECRUITING
NCT03793478
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
65
Enrollment(s)
28
Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Acute Myeloid Leukemia
RECRUITING
NCT06085755
Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer
61
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Stomach Neoplasm
ACTIVE_NOT_RECRUITING
NCT03523585
DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]
608
Enrollment(s)
227
Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
RECRUITING
NCT05491200
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
1,608
Enrollment(s)
12
Study location(s)
INTERVENTIONAL (PHASE4)
ST Elevated Myocardial Infarction
Dual Antiplatelet Therapy
NOT_YET_RECRUITING
NCT06665178
Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast Cancer
20
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer
6
7
8
9
10